Business Description
Olba Healthcare Holdings Inc
ISIN : JP3226700007
Description
Olba Healthcare Holdings Inc is a Japan-based holding company that engages in the wholesale distribution of medical diagnostic equipment and medical materials. It operates through the following business divisions: Medical Equipment, Supply, Processing, and Distribution (SPD), and Nursing Care Products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.08 | |||||
| Equity-to-Asset | 0.23 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 1.31 | |||||
| Interest Coverage | 110.96 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 3.44 | |||||
| Beneish M-Score | -2.22 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.7 | |||||
| 3-Year EBITDA Growth Rate | 30.3 | |||||
| 3-Year EPS without NRI Growth Rate | 43.9 | |||||
| 3-Year Book Growth Rate | 12.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.74 | |||||
| 9-Day RSI | 58.37 | |||||
| 14-Day RSI | 57.56 | |||||
| 6-1 Month Momentum % | 7.78 | |||||
| 12-1 Month Momentum % | 12.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.16 | |||||
| Quick Ratio | 0.95 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 22.9 | |||||
| Days Sales Outstanding | 70.69 | |||||
| Days Payable | 67.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.49 | |||||
| Dividend Payout Ratio | 0.31 | |||||
| 3-Year Dividend Growth Rate | 20.5 | |||||
| Forward Dividend Yield % | 6.99 | |||||
| 5-Year Yield-on-Cost % | 6.29 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 2.23 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.56 | |||||
| Operating Margin % | 1.79 | |||||
| Net Margin % | 1.18 | |||||
| FCF Margin % | -0.8 | |||||
| ROE % | 13.64 | |||||
| ROA % | 3.25 | |||||
| ROIC % | 6.71 | |||||
| ROC (Joel Greenblatt) % | 23.94 | |||||
| ROCE % | 17.38 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.02 | |||||
| PE Ratio without NRI | 9.03 | |||||
| Shiller PE Ratio | 12.67 | |||||
| PEG Ratio | 0.84 | |||||
| PS Ratio | 0.1 | |||||
| PB Ratio | 1.18 | |||||
| Price-to-Tangible-Book | 1.27 | |||||
| EV-to-EBIT | 5.7 | |||||
| EV-to-EBITDA | 5.7 | |||||
| EV-to-Revenue | 0.1 | |||||
| EV-to-FCF | -12.37 | |||||
| Price-to-Projected-FCF | 0.93 | |||||
| Price-to-Median-PS-Value | 1.33 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.49 | |||||
| Price-to-Graham-Number | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 3.93 | |||||
| Earnings Yield (Greenblatt) % | 17.54 | |||||
| FCF Yield % | -7.6 | |||||
| Forward Rate of Return (Yacktman) % | 14.75 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers